(Q37047025)

17 August 2017

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

17 August 2017

0 references

0 references

inflammation

0 references

author name string

C A Lamb

series ordinal

1

1 reference

PMC publication ID

3724198

17 August 2017

J C Mansfield

series ordinal

2

1 reference

17 August 2017

3 November 2010

1 reference

Frontline gastroenterology

17 August 2017

1 reference

17 August 2017

2

1 reference

17 August 2017

1

1 reference

17 August 2017

13-18

1 reference

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Fecal lactoferrin: a new parameter to monitor infliximab therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

A simple method for assessing intestinal inflammation in Crohn's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Measurement of fecal lactoferrin as a marker of fecal leukocytes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724198

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study

4 September 2018

1 reference

12 December 2020

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

12 December 2020

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

12 December 2020

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

12 December 2020

Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

1 reference

12 December 2020

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

12 December 2020

Faecal calprotectin in the assessment of Crohn's disease activity

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

1 reference

12 December 2020

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

1 reference

12 December 2020

Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease

1 reference

12 December 2020

Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease

1 reference

12 December 2020

Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives?

1 reference

12 December 2020

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms

1 reference

12 December 2020

Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease

1 reference

12 December 2020

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

1 reference

12 December 2020

Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation

1 reference

12 December 2020

Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion

1 reference

12 December 2020

Accuracy of four fecal assays in the diagnosis of colitis

1 reference

12 December 2020

Comparison of tests for fecal lactoferrin and fecal occult blood for colorectal diseases: a prospective pilot study

1 reference

12 December 2020

Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion

1 reference

12 December 2020

Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

1 reference

12 December 2020

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/FG.2010.001362

1 reference

17 August 2017

1 reference

PMC publication ID

3724198

17 August 2017

PubMed publication ID

23904968

1 reference

PMC publication ID

3724198